Startup Europe — The Sifted Podcast
Getir is laying off 2,500 employees to try and survive
Aug 24, 2023
This podcast discusses weight-loss drugs in Europe, struggles of Getir, NorthVolt's funding raise, Scottish startup ENOUGH fundraise, NatureMetrics' biodiversity focus, and the impact of the global run on AI hardware on startups.
29:39
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- EMLA raised €10 million for its weight management clinic using GLP1 drugs, addressing obesity concerns.
- Getir's layoff of 2,500 employees highlights the challenges faced by speedy grocery startups in the industry.
Deep dives
Weight Loss Drug Mania Reaches Europe
Copenhagen-based EMLA raised €10 million in Series A funding for its digital weight management clinic that combines digital access to doctors and nurses, personalized health coaching, and prescription weight loss drugs. The drugs, known as GLP1 drugs, are traditionally used to treat diabetes but have gained popularity for weight loss in the US. EMLA aims to help users discover the root causes of obesity and change daily habits. However, concerns remain about potential side effects and drug shortages.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
